Massachusetts Financial Services Co. MA bought a new stake in shares of Owens & Minor, Inc. (NYSE:OMI – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 100,823 shares of the company’s stock, valued at approximately $1,582,000. Massachusetts Financial Services Co. MA owned approximately 0.13% of Owens & Minor as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Owens & Minor by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock valued at $242,459,000 after purchasing an additional 162,182 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Owens & Minor by 5.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 48,286 shares of the company’s stock worth $1,339,000 after acquiring an additional 2,671 shares during the period. Public Employees Retirement System of Ohio bought a new stake in Owens & Minor during the 1st quarter valued at $120,000. Burney Co. bought a new position in shares of Owens & Minor in the 1st quarter worth $271,000. Finally, Linden Thomas Advisory Services LLC boosted its position in Owens & Minor by 10.2% during the second quarter. Linden Thomas Advisory Services LLC now owns 19,142 shares of the company’s stock valued at $258,000 after purchasing an additional 1,764 shares in the last quarter. Institutional investors own 98.04% of the company’s stock.
Owens & Minor Trading Up 0.9 %
Shares of OMI stock opened at $13.31 on Thursday. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a twelve month low of $11.42 and a twelve month high of $28.35. The company’s 50-day moving average price is $13.65 and its 200-day moving average price is $15.09. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of -20.48, a PEG ratio of 0.47 and a beta of 0.41.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on the stock. UBS Group decreased their target price on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. StockNews.com downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. Citigroup reduced their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a report on Tuesday, November 5th. JPMorgan Chase & Co. lowered their price target on shares of Owens & Minor from $22.00 to $18.00 and set an “underweight” rating on the stock in a report on Wednesday, August 21st. Finally, Robert W. Baird decreased their price target on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $18.50.
Insider Buying and Selling at Owens & Minor
In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares of the company’s stock, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 2.62% of the company’s stock.
Owens & Minor Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Read More
- Five stocks we like better than Owens & Minor
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Invest in the Best Canadian Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use the MarketBeat Excel Dividend Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.